Skip to content

Thorp: Pfizer Pregnancy Trial Halt and Placental Findings

Day 3 · 5:38:25 · James Thorp · Dean Allison · Shawn Buckley

  • 🚫 Pfizer’s Phase 2/3 pregnant-women trial stopped at only 350 participants after clinically significant neonatal adverse outcomes.
  • 📑 Results were buried deep in the report; Thorp’s later papers catalogued 37 adverse events across pregnancy and newborns.
  • 🧬 He displays classic vaccinated-placenta pathology and notes white papers co-authored with legal experts.

Halted trial data and histopathological observations.

← Thorp: Stillbirth Clusters in Fresno, Lionsgate and Ontario | Q&A: Evidence of Fertility Harm from the Vaccine →

Transcript

James Thorp · 5:38:25

This is Pfizer 5.3.6. I'm sorry.

Dean Allison · 5:38:28

No, no, no.

James Thorp · 5:38:28

Strike that. This is Pfizer Phase 2/3 trial, clinical trial of pregnant women. Okay. There was such adverse outcomes. That they stopped the trial with only 350 patients in it. Why? Because they were sweating bullets because there was clinically significant increase in adverse neonatal outcomes in those babies whose mothers received the COVID-19 injection. And then they buried this, uh, on like after 200 pages of gobbledygook, meaningless stuff so nobody would see it. I found it. Here's the data. So this is a second article that we published. Again, this is after 40 months, very similar findings, except we had 37 adverse events.

James Thorp · 5:39:30

37 Adverse events 27 of them during pregnancy, 10 of them in newborns. This is a typical placenta that I've seen that was a classic vaccinated placenta. This is probably not real meaningful to most of you. And there's a series of articles that were these— I would call these white papers. They are extensively cited They are first authored by a very, very brilliant attorney and a second author by myself, a maternal fetal medicine physician.

Shawn Buckley · 5:40:09

Dr. Thorpe, I'm going to stop you and ask a couple of questions and then turn you over to panel. But your, your slide presentation is going to be an exhibit.